Please Wait.....
Report
Live Cell Imaging Market By Product Type (Instruments, Accessories and Consumables, Software), By Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery), By Technology (Time-lapse Microscopy, Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High-Content Screening (HCS), Other Technologies), By End User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2023-11-01 I 285 Pages I Allied Market Research
The global live cell imaging market was valued at $2.3 billion in 2022 and is projected to reach $5.2 billion by 2032, registering a CAGR of 8.2% from 2023 to 2032.Live cell imaging stands as an advanced microscopy method enabling researchers to observe and analyze dynamic processes within living cells in real-time. In contrast to conventional techniques involving cell fixation and staining, live cell imaging offers the unique advantage of monitoring cellular behaviors, responses, and interactions without disrupting the natural cellular environment. Specialized microscopy technologies such as fluorescence microscopy, confocal microscopy, and super-resolution microscopy, combined with fluorescent dyes or genetically encoded markers aimed at specific cellular components, form the basis of this technique. By capturing images or videos over time, researchers can delve into processes such as cell division, migration, and signaling, fostering a comprehensive grasp of how cells function and operate within their dynamic environment.
The growth of the live cell imaging market is fueled by varioussignificant factors. These include the rising prevalence of chronic diseases, an increasing emphasis on regenerative medicine, and advancements in imaging probes. Diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions have become more prevalent, consequently driving up the demand for live cell imaging. Researchers leverage this technology to investigate the inner understandings of these diseases at a cellular level, aiding in comprehending their progression and paving the way for targeted therapeutic interventions. Real-time observation and analysis of cellular responses contribute to advancements in disease research and drug discovery.
Further, advances in imaging probes and contrast agents enhance the capabilities of live cell imaging, allowing for more specific and targeted observations. The development of genetically encoded fluorescent proteins, specialized dyes, and probes tailored for specific cellular structures or functions enhances the precision and versatility of live cell imaging techniques. These innovations contribute to the refinement of imaging modalities and expand the applications of live cell imaging across various research domains.Furthermore, advancements in live cell imaging technologies have provided researchers with unparalleled insights into studying the dynamic behaviors of cells. The ability to observe and analyze cellular processes in real-time enables scientists to comprehend the complexities of cell migration, differentiation, and signaling. This knowledge serves as a foundation for regenerative medicine, where controlling and directing cellular behavior are central to tissue regeneration.
In addition, emphasis on regenerative medicine extends to clinical applications and therapies that aim to restore or replace damaged tissues in patients. Live cell imaging plays a crucial role in monitoring the progress of these therapies, assessing the integration of transplanted cells and ensuring the functionality of regenerated tissues. This real-time feedback is invaluable for optimizing treatment protocols and ensuring patient safety.
The live cell imaging market is segmented into product type, application, technology, end user and region. On the basis of product type, the market is segregated into instruments, accessories & consumables, and software. The instruments segment is further divided into microscopes, standalone systems, and cell analyzers. On the basis of application, the market is classified into cell biology, stem cells, developmental biology, and drug discovery. On the basis of technology, the market is segregated into time-lapse microscopy, fluorescence resonance energy transfer (FRET), fluorescence recovery after photobleaching (FRAP), high-content screening (HCS), and other technologies. On the basis of end user, the market is divided into pharmaceutical & biotechnological companies, academic & research institutes, contract research organizations, and others. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (India, China, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global live cell imaging market are Sartorius AG, PerkinElmer, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Etaluma, Inc., Bruker Corporation, Merck KGaA, Nikon Corporation, Carl Zeiss AG and Danaher Corporation. The key players have adopted strategies such as product launch, partnership, and acquisition to expand their product portfolio
Key Benefits for Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the live cell imaging market analysis from 2022 to 2032 to identify the prevailing live cell imaging market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the live cell imaging market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global live cell imaging market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Product Type
- Instruments
- Type of Instrument
- Microscopes
- Standalone Systems
- Cell Analyzers
- Accessories and Consumables
- Software
By Application
- Cell Biology
- Stem Cells
- Developmental Biology
- Drug Discovery
By Technology
- Time-lapse Microscopy
- Fluorescence Resonance Energy Transfer (FRET)
- Fluorescence Recovery After Photobleaching (FRAP)
- High-Content Screening (HCS)
- Other Technologies
By End User
- Pharmaceutical and Biotechnological Companies
- Academic and Research Institutes
- Contract Research Organizations
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- PerkinElmer, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Etaluma, Inc.
- Bruker Corporation
- Merck KGaA
- Sartorius AG
- Carl Zeiss AG
- Nikon Corporation
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Technological advancements in live cell imaging systems
3.4.1.2. Rise in adoption of high-content screening in drug discovery
3.4.1.3. Rise in new product launches in live cell imaging
3.4.2. Restraints
3.4.2.1. High cost and maintenance of live cell imaging systems
3.4.3. Opportunities
3.4.3.1. Growth in opportunities in emerging markets
CHAPTER 4: LIVE CELL IMAGING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Instruments Live Cell Imaging Market by Type of Instrument
4.3. Accessories and Consumables
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Software
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: LIVE CELL IMAGING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Cell Biology
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Stem Cells
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Developmental Biology
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Drug Discovery
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: LIVE CELL IMAGING MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Time-lapse Microscopy
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Fluorescence Resonance Energy Transfer (FRET)
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Fluorescence Recovery After Photobleaching (FRAP)
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. High-Content Screening (HCS)
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Other Technologies
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
CHAPTER 7: LIVE CELL IMAGING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceutical and Biotechnological Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Academic and Research Institutes
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Contract Research Organizations
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: LIVE CELL IMAGING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Application
8.2.4. Market size and forecast, by Technology
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Product Type
8.2.6.1.2. Market size and forecast, by Application
8.2.6.1.3. Market size and forecast, by Technology
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Product Type
8.2.6.2.2. Market size and forecast, by Application
8.2.6.2.3. Market size and forecast, by Technology
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Product Type
8.2.6.3.2. Market size and forecast, by Application
8.2.6.3.3. Market size and forecast, by Technology
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Application
8.3.4. Market size and forecast, by Technology
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Product Type
8.3.6.1.2. Market size and forecast, by Application
8.3.6.1.3. Market size and forecast, by Technology
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Product Type
8.3.6.2.2. Market size and forecast, by Application
8.3.6.2.3. Market size and forecast, by Technology
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Product Type
8.3.6.3.2. Market size and forecast, by Application
8.3.6.3.3. Market size and forecast, by Technology
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Product Type
8.3.6.4.2. Market size and forecast, by Application
8.3.6.4.3. Market size and forecast, by Technology
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Product Type
8.3.6.5.2. Market size and forecast, by Application
8.3.6.5.3. Market size and forecast, by Technology
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Product Type
8.3.6.6.2. Market size and forecast, by Application
8.3.6.6.3. Market size and forecast, by Technology
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Application
8.4.4. Market size and forecast, by Technology
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Product Type
8.4.6.1.2. Market size and forecast, by Application
8.4.6.1.3. Market size and forecast, by Technology
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Product Type
8.4.6.2.2. Market size and forecast, by Application
8.4.6.2.3. Market size and forecast, by Technology
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Product Type
8.4.6.3.2. Market size and forecast, by Application
8.4.6.3.3. Market size and forecast, by Technology
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Product Type
8.4.6.4.2. Market size and forecast, by Application
8.4.6.4.3. Market size and forecast, by Technology
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Product Type
8.4.6.5.2. Market size and forecast, by Application
8.4.6.5.3. Market size and forecast, by Technology
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Product Type
8.4.6.6.2. Market size and forecast, by Application
8.4.6.6.3. Market size and forecast, by Technology
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Application
8.5.4. Market size and forecast, by Technology
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Product Type
8.5.6.1.2. Market size and forecast, by Application
8.5.6.1.3. Market size and forecast, by Technology
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Product Type
8.5.6.2.2. Market size and forecast, by Application
8.5.6.2.3. Market size and forecast, by Technology
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Product Type
8.5.6.3.2. Market size and forecast, by Application
8.5.6.3.3. Market size and forecast, by Technology
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Product Type
8.5.6.4.2. Market size and forecast, by Application
8.5.6.4.3. Market size and forecast, by Technology
8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. PerkinElmer, Inc.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Danaher Corporation
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Thermo Fisher Scientific Inc.
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.4. Agilent Technologies, Inc.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. Etaluma, Inc.
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Key strategic moves and developments
10.6. Bruker Corporation
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Merck KGaA
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. Sartorius AG
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Carl Zeiss AG
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.10. Nikon Corporation
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
LIST OF TABLES
TABLE 01. GLOBAL LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. LIVE CELL IMAGING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GLOBAL INSTRUMENTS LIVE CELL IMAGING MARKET, BY TYPE OF INSTRUMENT, 2022-2032 ($MILLION)
TABLE 04. LIVE CELL IMAGING MARKET FOR ACCESSORIES AND CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 05. LIVE CELL IMAGING MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GLOBAL LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 07. LIVE CELL IMAGING MARKET FOR CELL BIOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 08. LIVE CELL IMAGING MARKET FOR STEM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 10. LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 12. LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2022-2032 ($MILLION)
TABLE 13. LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET), BY REGION, 2022-2032 ($MILLION)
TABLE 14. LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP), BY REGION, 2022-2032 ($MILLION)
TABLE 15. LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING (HCS), BY REGION, 2022-2032 ($MILLION)
TABLE 16. LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
TABLE 17. GLOBAL LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 18. LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 19. LIVE CELL IMAGING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
TABLE 20. LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 21. LIVE CELL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 22. LIVE CELL IMAGING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 24. NORTH AMERICA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. NORTH AMERICA LIVE CELL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 28. U.S. LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 29. U.S. LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. U.S. LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 31. U.S. LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. CANADA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 33. CANADA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 34. CANADA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 35. CANADA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. MEXICO LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 37. MEXICO LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 38. MEXICO LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 39. MEXICO LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. EUROPE LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 41. EUROPE LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 42. EUROPE LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 43. EUROPE LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 44. EUROPE LIVE CELL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 45. GERMANY LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 46. GERMANY LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. GERMANY LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 48. GERMANY LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 49. FRANCE LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 50. FRANCE LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. FRANCE LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 52. FRANCE LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 53. UK LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 54. UK LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 55. UK LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 56. UK LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 57. ITALY LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 58. ITALY LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 59. ITALY LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 60. ITALY LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. SPAIN LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 62. SPAIN LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. SPAIN LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 64. SPAIN LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. REST OF EUROPE LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 66. REST OF EUROPE LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. REST OF EUROPE LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 68. REST OF EUROPE LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 69. ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 70. ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 72. ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 74. JAPAN LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 75. JAPAN LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. JAPAN LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 77. JAPAN LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. CHINA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 79. CHINA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 80. CHINA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 81. CHINA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 82. INDIA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 83. INDIA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 84. INDIA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 85. INDIA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. AUSTRALIA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 87. AUSTRALIA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 88. AUSTRALIA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 89. AUSTRALIA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 90. SOUTH KOREA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 91. SOUTH KOREA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 92. SOUTH KOREA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 93. SOUTH KOREA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 95. REST OF ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 98. LAMEA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 99. LAMEA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 100. LAMEA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 101. LAMEA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 102. LAMEA LIVE CELL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 103. BRAZIL LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 104. BRAZIL LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 105. BRAZIL LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 106. BRAZIL LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 107. SAUDI ARABIA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 108. SAUDI ARABIA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 109. SAUDI ARABIA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 110. SAUDI ARABIA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 111. SOUTH AFRICA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 112. SOUTH AFRICA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 113. SOUTH AFRICA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 114. SOUTH AFRICA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 115. REST OF LAMEA LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 116. REST OF LAMEA LIVE CELL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 117. REST OF LAMEA LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 118. REST OF LAMEA LIVE CELL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 119. PERKINELMER, INC.: KEY EXECUTIVES
TABLE 120. PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 121. PERKINELMER, INC.: PRODUCT SEGMENTS
TABLE 122. PERKINELMER, INC.: PRODUCT PORTFOLIO
TABLE 123. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 124. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 125. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 126. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 127. DANAHER CORPORATION: KEY STRATERGIES
TABLE 128. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 129. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 130. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
TABLE 131. THERMO FISHER SCIENTIFIC INC.: SERVICE SEGMENTS
TABLE 132. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 133. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 134. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 135. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 136. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 137. ETALUMA, INC.: KEY EXECUTIVES
TABLE 138. ETALUMA, INC.: COMPANY SNAPSHOT
TABLE 139. ETALUMA, INC.: PRODUCT SEGMENTS
TABLE 140. ETALUMA, INC.: PRODUCT PORTFOLIO
TABLE 141. ETALUMA, INC.: KEY STRATERGIES
TABLE 142. BRUKER CORPORATION: KEY EXECUTIVES
TABLE 143. BRUKER CORPORATION: COMPANY SNAPSHOT
TABLE 144. BRUKER CORPORATION: PRODUCT SEGMENTS
TABLE 145. BRUKER CORPORATION: PRODUCT PORTFOLIO
TABLE 146. BRUKER CORPORATION: KEY STRATERGIES
TABLE 147. MERCK KGAA: KEY EXECUTIVES
TABLE 148. MERCK KGAA: COMPANY SNAPSHOT
TABLE 149. MERCK KGAA: PRODUCT SEGMENTS
TABLE 150. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 151. SARTORIUS AG: KEY EXECUTIVES
TABLE 152. SARTORIUS AG: COMPANY SNAPSHOT
TABLE 153. SARTORIUS AG: PRODUCT SEGMENTS
TABLE 154. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 155. SARTORIUS AG: KEY STRATERGIES
TABLE 156. CARL ZEISS AG: KEY EXECUTIVES
TABLE 157. CARL ZEISS AG: COMPANY SNAPSHOT
TABLE 158. CARL ZEISS AG: PRODUCT SEGMENTS
TABLE 159. CARL ZEISS AG: PRODUCT PORTFOLIO
TABLE 160. NIKON CORPORATION: KEY EXECUTIVES
TABLE 161. NIKON CORPORATION: COMPANY SNAPSHOT
TABLE 162. NIKON CORPORATION: PRODUCT SEGMENTS
TABLE 163. NIKON CORPORATION: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. LIVE CELL IMAGING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF LIVE CELL IMAGING MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN LIVE CELL IMAGING MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN LIVE CELL IMAGING MARKET (2023-2032)
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTES
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. LOW BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL LIVE CELL IMAGING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. LIVE CELL IMAGING MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR ACCESSORIES AND CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. LIVE CELL IMAGING MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR CELL BIOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR STEM CELLS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET), BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP), BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING (HCS), BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. LIVE CELL IMAGING MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY 2022 AND 2032(%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF LIVE CELL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 31. LIVE CELL IMAGING MARKET BY REGION, 2022 AND 2032(%)
FIGURE 32. U.S. LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 33. CANADA LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 34. MEXICO LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 35. GERMANY LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 36. FRANCE LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 37. UK LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 38. ITALY LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 39. SPAIN LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF EUROPE LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 41. JAPAN LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 42. CHINA LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 43. INDIA LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 44. AUSTRALIA LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 45. SOUTH KOREA LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 46. REST OF ASIA-PACIFIC LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 47. BRAZIL LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 48. SAUDI ARABIA LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 49. SOUTH AFRICA LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 50. REST OF LAMEA LIVE CELL IMAGING MARKET, 2022-2032 ($MILLION)
FIGURE 51. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
FIGURE 54. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 55. COMPETITIVE DASHBOARD
FIGURE 56. COMPETITIVE HEATMAP: LIVE CELL IMAGING MARKET
FIGURE 57. TOP PLAYER POSITIONING, 2022
FIGURE 58. PERKINELMER, INC.: NET SALES, 2021-2023 ($MILLION)
FIGURE 59. PERKINELMER, INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 60. PERKINELMER, INC.: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 61. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 62. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 65. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 66. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 67. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 68. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 69. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 70. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 71. BRUKER CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 72. BRUKER CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 73. BRUKER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 74. BRUKER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 75. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
FIGURE 76. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 77. MERCK KGAA: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 78. SARTORIUS AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 79. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 80. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 81. CARL ZEISS AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 82. CARL ZEISS AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 83. CARL ZEISS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 84. NIKON CORPORATION: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 85. NIKON CORPORATION: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 86. NIKON CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security